The US Supreme Court signaled it’s likely to preserve full access to a widely used abortion pill as the justices heard arguments in a case carrying major stakes for reproductive rights and potentially this year’s elections.
Taking up the divisive issue for the first time since overturning the landmark Roe v. Wade decision in 2022, key justices on Tuesday voiced wariness about a legal attack on mifepristone, a drug now used in more than half the nation’s abortions.
The suit by anti-abortion doctors would roll back Food and Drug Administration steps that broadened mifepristone’s availability, including a 2021 decision ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.